Significant increase in hepatic expression of TUBA1A in NAFLD and NASH, linked to 14-3-3 proteins and associated with poor clinical outcome [105],upregulated in mice with hepatic steatosis and downregulated through dietary intervention normalizing the metabolic dysregulation [117]. Here, YWHAQ is linked to fatty liver disease.